KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Net Income towards Common Stockholders (2016 - 2025)

Johnson & Johnson's Net Income towards Common Stockholders history spans 16 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders changed N/A year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $26.8 billion, changed N/A, while the annual FY2023 figure was $21.8 billion, 1289.37% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $5.1 billion at Johnson & Johnson, down from $5.2 billion in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $21.7 billion in Q4 2023 and bottomed at -$232.0 million in Q3 2023.
  • The 4-year median for Net Income towards Common Stockholders is $4.4 billion (2021), against an average of $4.6 billion.
  • The largest YoY upside for Net Income towards Common Stockholders was 14575.0% in 2023 against a maximum downside of 142.03% in 2023.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at $3.7 billion in 2021, then plummeted by 95.96% to $148.0 million in 2022, then skyrocketed by 4084.46% to $6.2 billion in 2023, then fell by 17.39% to $5.1 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Net Income towards Common Stockholders are $5.1 billion (Q4 2025), $5.2 billion (Q3 2025), and $5.5 billion (Q2 2025).